Rizatriptan

Rizatriptan is a serotonin (5-HT1B/1D) receptor agonist and active pharmaceutical ingredient used in the acute treatment of migraine headaches. Mediocon Inc supplies high-purity Rizatriptan API conforming to IP / BP / EP / USP specifications from our GMP-certified facility in Aurangabad, Maharashtra, India.

Rizatriptan causes selective intracranial vasoconstriction and inhibits the release of pro-inflammatory neuropeptides, providing rapid relief from migraine pain. It is available in standard tablet and orally disintegrating tablet (ODT) formulations.

Key Features

• High-purity pharmaceutical grade API
• IP / BP / EP / USP compliant
• Full CoA and MSDS documentation
• GMP certified manufacturing

Applications

• Acute migraine treatment
• Cluster headache management
• Serotonin agonist formulations
• ODT and conventional tablet forms

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings